Transcript
Page 1: Training And Education Within Pharmaceutical Manufacturing Manupharma Summit 4 2005

Training and Education

within

Pharmaceutical ManufacturingDavid A. Gallup, Ed. D.

Principal

Training and Communications Group, Inc.

Page 2: Training And Education Within Pharmaceutical Manufacturing Manupharma Summit 4 2005

Agenda

Background Training Review Training Requirements Strategies to Ensure Compliance Is Training Always the Answer? Return on Investment Conclusions

Agenda

Page 3: Training And Education Within Pharmaceutical Manufacturing Manupharma Summit 4 2005

The End--First

Training isn’t always the answer. Training must provide a Return on

Investment

Agenda

Page 4: Training And Education Within Pharmaceutical Manufacturing Manupharma Summit 4 2005

Background

Personal Training and Communications Group, Inc.

Background

Page 5: Training And Education Within Pharmaceutical Manufacturing Manupharma Summit 4 2005

What is Training?

1. Change in Behavior to include:• Providing new or updated knowledge• Providing new or improve skill • Changing attitude

Training Review

Page 6: Training And Education Within Pharmaceutical Manufacturing Manupharma Summit 4 2005

What are the Training Requirements?

FDA regulates manufacturing, processing, packaging and holding of drugs in Code of Federal Regulations

CFR contains an important section regarding training: Section 21, Paragraph 211.25

Requirements

Page 7: Training And Education Within Pharmaceutical Manufacturing Manupharma Summit 4 2005

21 CFR 211.25 Personnel Qualifications

(a) Each person engaged in the manufacture, processing, packing, or holding of a drug product shall have education, training, and experience, or any combination thereof, to enable that person to perform the assigned functions. Training shall be in the particular operations that the employee performs and in current good manufacturing practice (including the current good manufacturing practice regulations in this chapter and written procedures required by these regulations) as they relate to the employee's functions.

Requirements

Page 8: Training And Education Within Pharmaceutical Manufacturing Manupharma Summit 4 2005

In Summary:

Pharmaceutical manufacturers must provide training to their personnel.

Requirements

Page 9: Training And Education Within Pharmaceutical Manufacturing Manupharma Summit 4 2005

What type of training must be provided?

Ensuring Compliance

Page 10: Training And Education Within Pharmaceutical Manufacturing Manupharma Summit 4 2005

Why are we developing materials this way?

Ensuring Compliance

Page 11: Training And Education Within Pharmaceutical Manufacturing Manupharma Summit 4 2005

Competency-Based Training

1. Identification of required skills or areas of knowledge to perform job

2. Development of training materials to provide: skill development and practice or specific “bits” of information

3. Implementation of the training materials

4. Evaluation to determine: ability to perform discrete skill or task ability to retain “bits” of information

Ensuring Compliance

Page 12: Training And Education Within Pharmaceutical Manufacturing Manupharma Summit 4 2005

What can happen if we don’t develop materials this way!

Ensuring Compliance

Page 13: Training And Education Within Pharmaceutical Manufacturing Manupharma Summit 4 2005

Competency-Based Training Design Process

Needs Analysis

Situation Analysis

Task Analysis

Objective Specification

Implementation Select, Design & ProduceTraining Materials

Select, Design & Produce

Evaluation MaterialsEnsuring Compliance

Page 14: Training And Education Within Pharmaceutical Manufacturing Manupharma Summit 4 2005

Is Training Always the Answer?

Training always the Answer?

Page 15: Training And Education Within Pharmaceutical Manufacturing Manupharma Summit 4 2005

Training vs. Non-Training

Training always the Answer?

Page 16: Training And Education Within Pharmaceutical Manufacturing Manupharma Summit 4 2005

How do we measure effect of training?

Immediate Change in behavior Delayed Change in behavior “Goodness” of Training Program Results of Training Program

Return on Investment

Page 17: Training And Education Within Pharmaceutical Manufacturing Manupharma Summit 4 2005

Evaluation MatrixWhat Can Be Evaluated Methods of

Measure

Stage 1. Trainee Knowledge PrinciplesFacts Techniques

ObservationOutputTest

Attitude Job PerformanceJob Behavior

Observation Checklist

Reports

Skill AttitudeActivity/job

ObservationInterviewQuestionnaire

Stage 2. Reaction Attitude to program InterviewQuestionnaire

Stage 3. Results Reduced CostsImproved QualityIncreased Quantity

BudgetFewer RejectsLarger Output

Return on Investment

Page 18: Training And Education Within Pharmaceutical Manufacturing Manupharma Summit 4 2005

What is Training?

Results of Training Program

=

Return on investment

Return on Investment

Page 19: Training And Education Within Pharmaceutical Manufacturing Manupharma Summit 4 2005

Return on Investment

Example:

Reduced waste costs in the granulation area following the completion of a competency-based, technical skill training program for operators and line tenders.

Return on Investment

Page 20: Training And Education Within Pharmaceutical Manufacturing Manupharma Summit 4 2005

Reduced Waste Costs/Product

$1,900

$2,000

$2,100

$2,200

$2,300

$2,400

$2,500

1994 1995

Return on Investment

Page 21: Training And Education Within Pharmaceutical Manufacturing Manupharma Summit 4 2005

Reduced Landfill Costs

250,000

260,000

270,000

280,000

290,000

300,000

310,000

320,000

330,000

1994 1995

Return on Investment

Page 22: Training And Education Within Pharmaceutical Manufacturing Manupharma Summit 4 2005

Savings From Reduced Waste

$0

$100,000

$200,000

$300,000

$400,000

$500,000

$600,000

$700,000

$800,000

$900,000

1994 1995

Return on Investment

Page 23: Training And Education Within Pharmaceutical Manufacturing Manupharma Summit 4 2005

Reduced Non-Conformances

0

200

400

600

800

1000

1200

1994 1995

Return on Investment

Page 24: Training And Education Within Pharmaceutical Manufacturing Manupharma Summit 4 2005

Increase in Planning Values

0%

5%

10%

15%

20%

25%

1994 1995 1996 1997

Return on Investment

Page 25: Training And Education Within Pharmaceutical Manufacturing Manupharma Summit 4 2005

Return on Investment

0

100,000

200,000

300,000

400,000

500,000

600,000

700,000

800,000

900,000

1995 1996

Return on Investment

Page 26: Training And Education Within Pharmaceutical Manufacturing Manupharma Summit 4 2005

The End—Really!

Training isn’t always the answer. Training must provide a Return on

Investment

Agenda


Recommended